1 drug(s) with this reaction
9,770 total reports
Device Difficult To Use has been reported as an adverse reaction across 1 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 9,770 adverse event reports mention device difficult to use in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with device difficult to use, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have device difficult to use listed in their FDA adverse event reports, sorted by report count:
In addition to device difficult to use, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
1 drug(s) manufactured by Amgen Inc have device difficult to use listed in their FDA adverse event reports: ERENUMAB-AOOE.
There are a combined 9,770 reports of device difficult to use across 1 Amgen Inc drug(s) in the FDA adverse event database.